Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014
- PMID: 28964382
- PMCID: PMC6485413
- DOI: 10.1016/j.amjcard.2017.08.017
Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014
Abstract
The prevalence of atrial fibrillation (AF) is increasing in the United States as the population ages, but national surveillance is lacking. This cross-sectional study (2006 to 2014) analyzed data from the Healthcare Cost and Utilization Project's Nationwide Emergency Department Sample, the National (Nationwide) Inpatient Sample, and the National Vital Statistics System. Event totals were estimated independently for emergency department (ED) visits, hospitalizations, and mortality, and then collectively after applying criteria to identify mutually exclusive events. Rates were calculated for AF as primary diagnosis or underlying cause of death (primary AF), as well as secondary diagnosis or contributing cause of death (co-morbid AF), and standardized by age to the 2010 US population. From 2006 to 2014, event rates increased for primary AF (249 to 268 per 100,000) and co-morbid AF (1,473 to 1,835 per 100,000). In 2014, an estimated 599,790 ED visits, 453,060 hospitalizations, and 21,712 deaths listed AF as primary. A total of 684,470 mutually exclusive primary AF and 4,695,997 mutually exclusive co-morbid AF events occurred. Among ED visits and hospitalizations with primary AF, the most common secondary diagnoses were hypertension, heart failure, ischemic heart disease, and diabetes. The mean cost per hospitalization with primary AF was $8,819. Mean costs were higher for those with co-morbid AF versus those without co-morbid AF among hospitalizations with a primary diagnosis of ischemic heart disease, heart failure, stroke, hypertension, or diabetes (all p ≤0.01). In conclusion, with the substantial health and economic impact of AF and an aging US population, improved diagnosis, prevention, management, and surveillance of AF are increasingly important.
Published by Elsevier Inc.
Figures

Similar articles
-
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.Value Health. 2006 Sep-Oct;9(5):348-56. doi: 10.1111/j.1524-4733.2006.00124.x. Value Health. 2006. PMID: 16961553
-
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning.Circulation. 2014 Jun 10;129(23):2371-9. doi: 10.1161/CIRCULATIONAHA.114.008201. Epub 2014 May 19. Circulation. 2014. PMID: 24842943
-
Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.Clin Cardiol. 2010 May;33(5):270-9. doi: 10.1002/clc.20759. Clin Cardiol. 2010. PMID: 20513065 Free PMC article.
-
Clinical service organisation for adults with atrial fibrillation.Cochrane Database Syst Rev. 2024 Jul 29;7(7):CD013408. doi: 10.1002/14651858.CD013408.pub2. Cochrane Database Syst Rev. 2024. PMID: 39072702 Free PMC article.
-
Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future.Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):105-16. doi: 10.1016/j.pcad.2015.07.002. Epub 2015 Jul 8. Prog Cardiovasc Dis. 2015. PMID: 26162957 Review.
Cited by
-
Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation.World J Cardiol. 2022 Oct 26;14(10):537-545. doi: 10.4330/wjc.v14.i10.537. World J Cardiol. 2022. PMID: 36339889 Free PMC article.
-
Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results.J Cardiovasc Dev Dis. 2024 Mar 31;11(4):109. doi: 10.3390/jcdd11040109. J Cardiovasc Dev Dis. 2024. PMID: 38667727 Free PMC article.
-
Vaccination and risk of lone atrial fibrillation in the active component United States military.Hum Vaccin Immunother. 2019;15(3):669-676. doi: 10.1080/21645515.2018.1549453. Epub 2019 Jan 8. Hum Vaccin Immunother. 2019. PMID: 30444675 Free PMC article.
-
Diltiazem Dosing Strategies in the Management of Atrial Fibrillation With Rapid Ventricular Rate.Cureus. 2021 Oct 16;13(10):e18829. doi: 10.7759/cureus.18829. eCollection 2021 Oct. Cureus. 2021. PMID: 34804686 Free PMC article.
-
Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation.JCI Insight. 2020 Sep 3;5(17):e126525. doi: 10.1172/jci.insight.126525. JCI Insight. 2020. PMID: 32879139 Free PMC article.
References
-
- Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study. Circulation 1998;98:946–952. - PubMed
-
- Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:2672–2713. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical